We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+17.96%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$439M
AUM Growth
-$225M
Cap. Flow
-$271M
Cap. Flow %
-61.73%
Top 10 Hldgs %
45.18%
Holding
219
New
28
Increased
28
Reduced
52
Closed
34

Top Buys

Rank Stock Value
1
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$7.26M
2
GSAH.U
GS Acquisition Holdings Corp II Units, each consisting of one share of Class A Common Stock and one-
GSAH.U
+$5.54M
3
LM
Legg Mason, Inc.
LM
+$5.11M
4
WUBA
58.com Inc
WUBA
+$3.71M
5
MEET
The Meet Group, Inc. Common Stock
MEET
+$2.44M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$48.9M
2
S
Sprint Corporation
S
+$33.6M
3
CY
Cypress Semiconductor
CY
+$29.2M
4
WBC
WABCO HOLDINGS INC.
WBC
+$26M
5
MLNX
Mellanox Technologies, Ltd.
MLNX
+$22.6M

Sector Composition

Rank Sector Weight
1 Financials 19.16%
2 Technology 13.89%
3 Consumer Discretionary 8.13%
4 Healthcare 7.58%
5 Utilities 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
126
AbbVie
ABBV
$442B
$253K 0.06%
+2,577
New +$227K
FMCIW
127
DELISTED
Forum Merger II Corporation Warrant
FMCIW
$250K 0.06%
53,175
-315,725
-86% -$676K
PRGO icon
128
Perrigo
PRGO
$1.78B
$249K 0.06%
4,500
– –
CORT icon
129
Corcept Therapeutics
CORT
$12.1B
$246K 0.06%
14,600
– –
CI icon
130
Cigna
CI
$72.4B
$244K 0.06%
1,300
– –
HCA icon
131
HCA Healthcare
HCA
$89.1B
$243K 0.06%
+2,500
New +$260K
SDS icon
132
ProShares UltraShort S&P500
SDS
$371M
$243K 0.06%
500
-1,100
-69% -$623K
META icon
133
Meta Platforms (Facebook)
META
$1.53T
$238K 0.05%
+1,050
New +$219K
TPL icon
134
Texas Pacific Land
TPL
$25.2B
$238K 0.05%
+3,600
New +$221K
BDX icon
135
Becton Dickinson
BDX
$49.4B
$227K 0.05%
+974
New +$235K
CVS icon
136
CVS Health
CVS
$120B
$227K 0.05%
3,500
– –
BIO icon
137
Bio-Rad Laboratories Class A
BIO
$9.53B
$226K 0.05%
+500
New +$221K
CNH
138
CNH Industrial
CNH
$17.1B
$213K 0.05%
34,757
+3,734
+12% +$20.7K
TV icon
139
Televisa
TV
$1.48B
$186K 0.04%
35,500
+6,000
+20% +$33.2K
GE icon
140
GE Aerospace
GE
$382B
$154K 0.04%
4,514
-1,605
-26% -$54.1K
ADNWW
141
DELISTED
Advent Technologies Holdings Warrant
ADNWW
$134K 0.03%
243,300
-175,300
-42% -$56.7K
BRSL
142
Brightstar Lottery PLC
BRSL
$2.07B
$134K 0.03%
15,000
+4,000
+36% +$31.2K
APG icon
143
APi Group
APG
$18.5B
$131K 0.03%
+16,208
New +$123K
EVH icon
144
Evolent Health
EVH
$464M
$130K 0.03%
18,300
-400
-2% -$2.68K
SSP icon
145
E.W. Scripps
SSP
$307M
$126K 0.03%
14,400
-100
-0.7% -$802
MSGN
146
DELISTED
MSG Networks Inc.
MSGN
$109K 0.02%
11,000
-500
-4% -$5.71K
SNAXW
147
DELISTED
Stryve Foods, Inc. Warrant
SNAXW
$105K 0.02%
243,600
– –
LATNW
148
DELISTED
Union Acquisition Corp. II Warrant
LATNW
$103K 0.02%
293,700
– –
GIX.WS
149
DELISTED
GigCapital2, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $11.50
GIX.WS
$102K 0.02%
203,500
– –
CCO icon
150
Clear Channel Outdoor Holdings
CCO
$1.23B
$94K 0.02%
90,000
-44,500
-33% -$41.8K
4 5
6
7 8

Similar funds

RCM
Redwood Capital Management New York $674M AUM 99.78% 1-Year Est. Return
DPC
Dream Peak Capital Hong Kong $675M AUM
BFA
Blueprint Financial Advisors Greensboto, North Carolina $675M AUM 24.91% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
CHCM
Columbus Hill Capital Management Short Hills, New Jersey $673M AUM 24.63% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Gabelli & Co Investment Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Gabelli & Co Investment Advisers held 219 positions worth $439M, down 34% from $664M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Gabelli & Co Investment Advisers withdrew a net $271M in Q2 2020, closing 34 positions and reducing 52 holdings. Its most notable exit was Allergan plc, an estimated $48.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 11% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Gabelli & Co Investment Advisers opened a new position in Portola Pharmaceuticals, Inc. worth $9.39M.

  • Gabelli & Co Investment Advisers's largest Q2 2020 buy was Portola Pharmaceuticals, Inc.: 521,822 shares worth $9.39M.
  • Gabelli & Co Investment Advisers added most to Legg Mason, Inc. in Q2 2020, an estimated $5.11M increase.
  • Gabelli & Co Investment Advisers's biggest Q2 2020 reduction was Tech Data Corp, cutting an estimated $6.65M.
  • Gabelli & Co Investment Advisers fully exited Allergan plc in Q2 2020, selling an estimated $48.9M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 45% of its $439M portfolio in Q2 2020.
  • Gabelli & Co Investment Advisers opened 28 new positions and closed 34 in Q2 2020.
  • Gabelli & Co Investment Advisers's portfolio value fell 34% quarter-over-quarter to $439M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.